Follow the CHEMBIO DIAGNOSTICS, INC. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 2 May 2023 (Retenue fiscale). Among the most active insiders: Angelico Paul. Every trade is free.
21
Insider Decl.
n/a
Thresholds
€222,810
5 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CHEMBIO DIAGNOSTICS, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
16Σ signal
Buys €222,810n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,996 of 29,064 companies
18.5
score / 100
Value
23
Quality
15
FCF yld-4.0%
Earn yld-5.1%
EV/EBITDA·
ROE-40%
Gross mgn17%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
195,938 shares@ US$0.443.4% of flowCommon StockSEC:0000899243-23-010947:0
Canonical exit: 3 Jul 2023 (T+90)
21 of 21 declarations
Acerca de CHEMBIO DIAGNOSTICS, INC.
CHEMBIO DIAGNOSTICS, INC. es una empresa centrada en el desarrollo de pruebas de diagnóstico para enfermedades infecciosas. Cotiza en el NASDAQ bajo el símbolo CEMI.